NasdaqCM - Nasdaq Real Time Price USD

Intensity Therapeutics, Inc. (INTS)

0.4200
-0.0800
(-16.00%)
At close: May 16 at 4:00:02 PM EDT
0.4300
+0.01
+(2.38%)
After hours: May 16 at 7:58:33 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
15,236
16,585
8,319
7,550
7,996.4990
Operating Income
-15,236
-16,585
-8,319
-7,550
-7,996.4990
Net Non Operating Interest Income Expense
189
314
19
-80
-14.1580
Other Income Expense
--
3
-2,238
48
115.5130
Pretax Income
-15,012
-16,268
-10,538
-7,582
-7,895.1440
Net Income Common Stockholders
-15,012
-16,268
-11,862
-7,582
-7,895.6000
Diluted NI Available to Com Stockholders
-15,012
-16,268
-11,862
-7,582
-7,895.6000
Basic EPS
-1.05
--
-1.38
-2.19
-0.60
Diluted EPS
-1.05
--
-1.38
-2.19
-0.60
Basic Average Shares
14,272.9000
--
8,616.3240
3,463.6350
13,099.3770
Diluted Average Shares
14,272.9000
--
8,616.3240
13,099.3770
13,099.3770
Total Operating Income as Reported
-15,236
-16,585
-8,319
-7,550
-8,013.7220
Rent Expense Supplemental
--
--
--
142
153
Total Expenses
15,236
16,585
8,319
7,550
7,996.4990
Net Income from Continuing & Discontinued Operation
-15,012
-16,268
-10,538
-7,582
-7,895.6000
Normalized Income
-15,012
-16,268
-8,276
-7,582
-7,895.6000
Interest Income
189
314
324
2
2.6090
Interest Expense
--
0
305
82
16.7670
Net Interest Income
189
314
19
-80
-14.1580
EBIT
-14,919
-16,268
-10,233
-7,500
-7,878.3770
EBITDA
-14,919
-16,268
-10,233
-7,500
-7,878.3770
Net Income from Continuing Operation Net Minority Interest
-15,012
-16,268
-10,538
-7,582
-7,895.6000
Total Unusual Items Excluding Goodwill
0
0
-2,262
0
--
Total Unusual Items
0
0
-2,262
0
--
Normalized EBITDA
-14,919
-16,268
-7,971
-7,500
-7,878.3770
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 6/30/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

WINT Windtree Therapeutics, Inc.
0.8280
-0.24%
 
ENTO Entero Therapeutics, Inc.
0.4243
-1.33%
 
MTVA MetaVia Inc.
0.6845
+1.29%
 
SPRB Spruce Biosciences, Inc.
0.0650
+0.15%
 
SCNI Scinai Immunotherapeutics Ltd.
2.9100
+5.43%
 
TOVX Theriva Biologics, Inc.
0.5588
+3.27%
 
RLMD Relmada Therapeutics, Inc.
0.4610
+11.51%
 
KAPA Kairos Pharma, Ltd.
0.6210
+0.98%
 
FHTX Foghorn Therapeutics Inc.
4.4300
+2.78%
 
VOR Vor Biopharma Inc.
0.1769
+3.51%